Last reviewed · How we verify
hypertonic dextrose prolotherapy
At a glance
| Generic name | hypertonic dextrose prolotherapy |
|---|---|
| Sponsor | National Yang Ming Chiao Tung University Hospital |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Platelet-Rich Plasma and Prolotherapy for Plantar Fasciitis (NA)
- Combined Effect of Prolotherapy and Personalized Physical Activity on Knee Osteoarthritis Progression (NA)
- Precision Medicine for Sng/Pain Control (NA)
- Effects of Steroid, Dextrose Prolotherapy, and Platelet-Rich Plasma Injections in Knee Joint OA Patients (NA)
- Effects of Intra-articular Hypertonic Dextrose and Hyaluronic Acid on Primary Knee Osteoarthritis. (PHASE3)
- Therapeutic Effect of Using Injectable Hypertonic Saline 5% Versus Injectable Dextrose 20% on Pain in Painful Cases of Disc Displacement with Reduction (NA)
- Therapeutic Effect of Proliferative Therapy (prolotherapy) on Pain Using Injectable Hypertonic Dextrose 25% Versus Injectable Dextrose 10% in Retrodiscal Tissues in Patients with Anterior Disc Displacement with Reduction: a Randomized Clinical Trial . (PHASE2, PHASE3)
- Caudal Epidural Prolotherapy Versus Steroids in Failed Back Surgery Syndrome (PHASE2, PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |